[go: up one dir, main page]

NO20010860L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20010860L
NO20010860L NO20010860A NO20010860A NO20010860L NO 20010860 L NO20010860 L NO 20010860L NO 20010860 A NO20010860 A NO 20010860A NO 20010860 A NO20010860 A NO 20010860A NO 20010860 L NO20010860 L NO 20010860L
Authority
NO
Norway
Prior art keywords
new connections
prevention
formula
treatment
acceptable salts
Prior art date
Application number
NO20010860A
Other languages
English (en)
Other versions
NO20010860D0 (no
Inventor
Amin Kosrat
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20010860D0 publication Critical patent/NO20010860D0/no
Publication of NO20010860L publication Critical patent/NO20010860L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Nye forbindelser, og terapeutisk akseptable salter derav av formel (I) I som inhiberer eksogent eller endogent stimulert mavesyresekresjon og således kan anvendes i forebyggelse og behandling av gastrointestinale inflammatoriske sykdommer.
NO20010860A 1998-08-21 2001-02-20 Nye forbindelser NO20010860L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (2)

Publication Number Publication Date
NO20010860D0 NO20010860D0 (no) 2001-02-20
NO20010860L true NO20010860L (no) 2001-04-23

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010860A NO20010860L (no) 1998-08-21 2001-02-20 Nye forbindelser

Country Status (20)

Country Link
US (3) US6579884B1 (no)
EP (2) EP1411056A3 (no)
JP (1) JP2002523415A (no)
KR (1) KR20010072798A (no)
CN (1) CN1329613A (no)
AR (1) AR020226A1 (no)
AT (1) ATE280768T1 (no)
AU (1) AU5767999A (no)
BR (1) BR9913103A (no)
CA (1) CA2339286A1 (no)
DE (1) DE69921483T2 (no)
DK (1) DK1105391T3 (no)
ES (1) ES2229763T3 (no)
IL (1) IL141166A0 (no)
NO (1) NO20010860L (no)
PT (1) PT1105391E (no)
SE (1) SE9802794D0 (no)
SI (1) SI1105391T1 (no)
WO (1) WO2000011000A2 (no)
ZA (1) ZA200100913B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CN100549011C (zh) * 2002-09-19 2009-10-14 先灵公司 用作细胞周期蛋白依赖性激酶抑制剂的新颖咪唑并吡啶
AR041292A1 (es) * 2002-09-19 2005-05-11 Schering Corp Pirazolopiridinas como inhibidores de quinasa dependientes de ciclina
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
JP4977465B2 (ja) * 2004-07-28 2012-07-18 武田薬品工業株式会社 ピロロ［２，３−ｃ］ピリジン化合物、その製造方法および用途
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
WO2008065199A1 (en) * 2006-12-01 2008-06-05 Galapagos N.V. Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
US20100267712A1 (en) * 2007-09-27 2010-10-21 The United States of America, as represented by the Secretary, Department of Health and Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
CN105919998B (zh) 2009-07-09 2021-08-24 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法
WO2025058459A1 (ko) * 2023-09-15 2025-03-20 (주)휴온스 신규한 이미다조피리딘계 화합물 및 이를 유효성분으로 포함하는 위장관 염증질환 또는 위산-관련 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2167362T3 (es) * 1993-04-22 2002-05-16 Byk Gulden Lomberg Chem Fab Sales de piridinio y su utilizacion para combatir a bacterias helicobacter.
UA48122C2 (uk) 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
JPH10505330A (ja) 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング ハロゲンイミダゾピリジン
EP0773946B1 (de) * 1994-07-28 2002-03-27 Byk Gulden Lomberg Chemische Fabrik GmbH Imidazopyridin-azolidinone
AU700737B2 (en) 1994-07-28 1999-01-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridines
WO1996003404A1 (de) * 1994-07-28 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylimidazopyridine
WO1997027192A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridine
DE19602853A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
AR020226A1 (es) 2002-05-02
EP1105391A2 (en) 2001-06-13
DK1105391T3 (da) 2005-01-24
WO2000011000A3 (en) 2000-06-15
KR20010072798A (ko) 2001-07-31
CA2339286A1 (en) 2000-03-02
PT1105391E (pt) 2005-01-31
AU5767999A (en) 2000-03-14
EP1411056A3 (en) 2004-04-28
NO20010860D0 (no) 2001-02-20
ES2229763T3 (es) 2005-04-16
DE69921483D1 (de) 2004-12-02
JP2002523415A (ja) 2002-07-30
US20030220364A1 (en) 2003-11-27
IL141166A0 (en) 2002-02-10
WO2000011000A2 (en) 2000-03-02
DE69921483T2 (de) 2006-02-02
EP1411056A2 (en) 2004-04-21
BR9913103A (pt) 2001-05-08
US20050154007A1 (en) 2005-07-14
ATE280768T1 (de) 2004-11-15
US6579884B1 (en) 2003-06-17
EP1105391B1 (en) 2004-10-27
SE9802794D0 (sv) 1998-08-21
SI1105391T1 (en) 2005-02-28
CN1329613A (zh) 2002-01-02
US6790960B2 (en) 2004-09-14
ZA200100913B (en) 2002-05-02

Similar Documents

Publication Publication Date Title
NO20010860L (no) Nye forbindelser
NO20010861L (no) Nye forbindelser
SE9801526D0 (sv) New compounds
SE9704404D0 (sv) New compounds
SE9700661D0 (sv) New compounds
TR200100805T2 (tr) Tetrahidropiridoeterler
CA2256687A1 (en) Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
SE9401197D0 (sv) Active compounds
SE0102808D0 (sv) New compounds
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20051847L (no) Eikosapentaensyre (EPA) for behandling av anoreksia nevrosa (AN) og bulimi.
WO2002074735A3 (de) Biurethanderivate
NO954928D0 (no) Nye aktive forbindelser
SE0102640D0 (sv) Novel compounds
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
NZ329716A (en) Sulfonamide substituted derivatives and medicaments thereof
AR044855A1 (es) Compuesto de imidazopiridina
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
NO20072340L (no) Difluorsubstituerte Imidazopyridiner
ATE382616T1 (de) Neue verbindungen
NO921691L (no) Farmasoeytisk preparat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application